Main
>
ONCOLOGY (**)
>
Breast Cancer>MET ***
>
Treatment
>
Co: USA. A. BevacizuMAb BioSimilar+
>
(*) USA Approval Year: 2017.
(*) USA Approval Year: 2017.'s products
This section has no products